Clinical Trial Update: Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis [NA]

View source ↗

Summary

This clinical trial compares Mineral Trioxide Aggregate (MTA) and Biodentine for complete pulpotomy in symptomatic irreversible pulpitis and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Irreversible Pulpitis

Drugs mentioned

• Biodentine (tricalcium silicate cement)
• Mineral Trioxide Aggregate (MTA) (Mineral Trioxide Aggregate)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Symptomatic Irreversible Pulpitis (SIP) | NA | Status: RECRUITING